This is a re-post from PhilBaumann.com [1]. It is being published here so that eyeforpharma readers can read and comment. Ellen Hoenig Carlson compiled an ebook of insights and suggestions for helping the pharmaceutical and other health care industries adapt to 21st Century challenges and opportunities. Ellen is editor of AdvanceMarketWoRx [2] and she asked me to contribute to her project. She's sincerely devoted to the goal of improving pharmaceutical marketing processes in order to deliver the best possible points of care to patients. She shares valuable thoughts and links and content on Twitter and you can follower her here [3]. In addition to myself, contributors include an anthropologist, an e-Patient, some consultants and a healthcare recruiter. [1] http://philbaumann.com/2009/12/23/pharma-social-media-best-strategic-learning-investment-for-2010/?preview=true&preview_id=2525&preview_nonce=e26c40f91c [2] http://advancemarketworx.com/ [3] http://twitter.com/ellenhoenig
This is a re-post from PhilBaumann.com. It is being published here so that eyeforpharma readers can read and comment.
Ellen Hoenig Carlson compiled an ebook of insights and suggestions for helping the pharmaceutical and other health care industries adapt to 21st Century challenges and opportunities. Ellen is editor of AdvanceMarketWoRx and she asked me to contribute to her project. She's sincerely devoted to the goal of improving pharmaceutical marketing processes in order to deliver the best possible points of care to patients. She shares valuable thoughts and links and content on Twitter and you can follower her here.
In addition to myself, contributors include an anthropologist, an e-Patient, some consultants and a healthcare recruiter.
All of the contributing perspectives are unique. For example, Andrew Spong PhD, founder of #hcsmeu (a Twitter chat for European healthcare and social media passionates), invokes Martin Heidegger when discussing Authenticity. How often do you get that in the context of health care marketing?
Susanah Fox, strategist for PEW, talks about how cultural changes affect patient advocacy. And my Twitter mates Steve Woodruff, Jonathan Richman, Wendy Blackburn, John Mack, and Angela Dunn offer their visions and advice.
You can download the ebook here. Read it: it's important that the public and marketers understand our relationship with Technology. Marketing - especially pharmaceutical and healthcare - is about achieving a simple goal: connecting points of suffering with points of care. That's not easy. It's hard and requires creativity, ethics, discipline, knowledge, wisdom, leadership and hope. Best Strategic Learning Investment in 2010
What do you think? What are your goals and needs and plans for 2010? What would you like to learn in 2010 that you believe could help make a difference in the industry? Let us know what you think.
blog comments powered by DisqusKevin Appareti, global director for Medical Science Liaison at Philips Healthcare, explains how to motivate KOLs and how to measure their value
The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs